Trevi Therapeutics Inc
NASDAQ:TRVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Trevi Therapeutics Inc
NASDAQ:TRVI
|
US |
|
R
|
Relx PLC
XHAN:RDEB
|
UK |
|
Kbc Groep NV
XBRU:KBC
|
BE |
|
I
|
Innox Corp
KOSDAQ:088390
|
KR |
|
P
|
PepsiCo Inc
F:PEP
|
US |
|
M
|
Mitsubishi Corp
XMUN:MBI
|
JP |
|
Bastogi SpA
MIL:B
|
IT |
|
NGK Spark Plug Co Ltd
OTC:NGKSY
|
JP |
|
Sphere 3D Corp
NASDAQ:ANY
|
CA |
|
Jupiter Fund Management PLC
F:4JF
|
UK |
|
C
|
Conagra Brands Inc
DUS:CAO
|
US |
|
F
|
Frasers Property Thailand Industrial Freehold & Leasehold REIT
SET:FTREIT
|
TH |
|
C
|
CubeSmart
F:UK8
|
US |
|
H
|
Haier Smart Home Co Ltd
OTC:QIHCF
|
CN |
|
S
|
SoftBank Group Corp
SWB:SFT
|
JP |
|
Komercni Banka as
F:KONN
|
CZ |
|
L
|
LPL Financial Holdings Inc
F:7LI
|
US |
|
Yungjin Pharm Co Ltd
KRX:003520
|
KR |
|
B
|
Bloomios Inc
OTC:BLMS
|
US |
|
Gabriel Resources Ltd
XTSX:GBU
|
UK |
|
D
|
Daemyung SonoSeason Co Ltd
KOSDAQ:007720
|
KR |
|
Sanford Ltd
NZX:SAN
|
NZ |
Bankruptcy Probability
Trevi Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Trevi Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Trevi Therapeutics Inc
NASDAQ:TRVI
|
2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
637.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
358.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
341.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
312.6B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
162.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Trevi Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Trevi Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.